GenAI for R&D Organizations: From Experimentation to Scale
Discover how R&D organizations can evolve from AI conceptualization to transformative impact, focusing on strategies for large-scale adoption.
Join Yiannis Kiachopoulos, CEO of Causaly, as he deep dives into Generative AI (GenAI) and the challenges and opportunities it currently presents for Life Science research.
Discover how R&D organizations can evolve from AI conceptualization to transformative impact, focusing on strategies for large-scale adoption within existing scientific workflows for seamless integration and operational excellence.
AI in Pharma 2024
Explore the role of Large Language Models (LLMs) in pharmaceutical research and the transformative potential of GenAI in enabling knowledge-based organizations.
Challenges in Scaling AI Initiatives
Learn how to navigate the complexities of scaling AI solutions and discover strategies to transition from experimentation to full-scale implementation.
Blueprint for AI Success: Technology, Process, Partnerships
Set your team up for success, discover how to drive AI innovations in R&D through technology, process, and strategic partnerships.
About the speakers
Thank you!
You can watch the webinar now
Get to know Causaly
What would you ask the team behind life sciences’ most advanced AI? Request a demo and get to know Causaly.
Request a demo